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The long-term cerebral effects of general anaesthesia at the extremes of age are currently enjoying attention. In children, the 
concern is that exposure to anaesthesia when less than 4 years of age may cause subsequent learning disabilities and behavioural 
changes. However, clinical equipoise exists as the available human studies are imperfect and the results of the large-scale 
multinational trials are not yet available. This structured narrative review summarises the overwhelming amount of information 
available.
‘Everything should be as simple as it can be, but not simpler.’ 
(Albert Einstein)
‘An estimated 6 million children (including 1.5 million infants) 
undergo surgery and anaesthesia each year in the USA alone, 
so the clinical relevance of anaesthetic neurotoxicity is an 
urgent matter of public health.’1
Animal anaesthesia associated developmental 
neurotoxicity (AADN) studies: the evidence
‘Studies in rodents and primates have (convincingly) shown 
that anaesthesia is neurotoxic to the developing brain after 
exposure in the neonatal period.’2
Early research demonstrating that halothane impaired rat neural 
synaptogenesis and learning was largely ignored.3,4 The current 
concerns were sparked by Jevtovic-Todorovic and colleagues’5 
evidence that day 7 postnatal (P7) rats exposed to a ‘triple 
cocktail’ of midazolam, isoflurane, and nitrous oxide exhibited 
accelerated neuronal apoptosis during synaptogenesis (Table 1) 
followed by impaired cognitive function (learning, memory, 
behaviour) in later life.
Similar findings have been observed with non-anaesthetic 
N-methyl-D-aspartate (NMDA) glutamate receptor antagonists,6 
other volatile anaesthetics (sevoflurane, halothane, desflurane), 
xenon, propofol, barbiturates and benzodiazepines.7−13 The 
injury is worse when younger animals are exposed to larger 
dosages for longer periods.6,7,14−19 The cognitive consequences of 
these injuries invariably continue into the adulthood of the 
animal, expressed as memory impairment and autism-like 
behavioural changes.5,9,11,14,20,21
The evidence that anaesthetics damage the developing non-
human brain therefore appears robust,22 a recent review 
identifying 55 rodent and 7 primate studies of relevance.2
Animal AADN studies: critical evaluation
Despite animal evidence raising the question whether AADN 
exists in humans, critical questions have been posed about 
this evidence. ‘The clinical significance of these observations 
remains controversial.’23
Critical evaluation of the available animal studies raises many 
questions:
(1)  It is unclear whether it is permissible to extrapolate 
animal models of AADN to human infants.24
(2)  Anaesthesia dosages differ significantly between 
animals and humans, animals requiring greater dosages 
due to their increased resting metabolic rates. For 
example, the propofol induction dose in infant mice is 
200 mg/kg7 while ketamine levels required to maintain 
anaesthesia in primates are five- to tenfold those in 
humans.17 Although animals need higher dosages 
compared with humans, many studies far exceeded the 
required dose in animals.
(3)  The duration of exposure to anaesthetics in animal 
experiments far exceeds that typical in human surgery.25 
Rat studies have typically involved six hours of anaesthetic 
exposure.5,6,14,17,26 If the average lifespan of rats and 
humans is 760 and 28 105 days respectively, a six-hour 
rat anaesthetic extrapolates to a 222-hour child exposure.
(4)  The proviso for initiation of neurotoxicity is that 
anaesthesia exposure must occur during the vulnerable 
period of neural development. However, the time-windows 
for vulnerability to AADN differ between species.27
(4.1)  Human and animal brains develop very differently with 
rats being altricial, while humans are a precocial 
species.23 Altricial and precocial are terms that refer to 
species that at birth are immature and relatively well 
developed respectively. Rats and humans undergo 
rapid periods of brain development after birth and in 
utero respectively.
(4.2)  The associations between peak synaptogenesis in 
humans and animals are not well defined. Postnatal 
day 7 in rats corresponds with peak synaptogenesis, the 
most vulnerable period of neurological development in 
rats.5 The classic rat model that employs 7-day-old (P7) 
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rats is, however, not representative of human neonatal 
brains, but reflects brain development between 16 and 
22  weeks’ gestation. Similarly, brain development in 
5-day-old primates equates to human brains between 
20 and 22  weeks’ gestation.28 These observations 
suggests that exposure ‘in utero’ may represent the 
most vulnerable time.
(5)  Less physiological neurodevelopmental apoptosis 
occurs in animal compared with human brains. 
(Physiological) apoptosis occurs in only 0.5% to 1% of 
rodent neurons but in up to 50% of human neurons.24 
Excess apoptosis may have a more pronounced 
deleterious effect in a species that does not have spare 
or excess neurons.
(6)  The presence of physiological trespass in animal models 
may limit the applicability thereof to humans. Animal 
studies have not used the same standards of airway 
control, monitoring or interventions to restore deranged 
physiology (hypoxia, hypotension, low cardiac output, 
hypoglycaemia, hypercarbia etc.) as in human 
anaesthesia and surgery25 with some new-born animals 
dying during anaesthesia exposure.2
(7)  Although strongly denied, it has been suggested that 
rodent pups do not suckle after anaesthesia; 
malnutrition has been linked to a decline in brain growth 
and learning.25
(8)  General anaesthetics do not consistently cause neural 
damage, a number of animal models refuting the 
existence of AADN. Near-term pregnant sheep exposed 
to four hours of midazolam-thiopentone-isoflurane 
anaesthesia exhibited improved foetal systemic and 
cerebral oxygenation with no histological neurotoxicity.29 
Neonatal pigs exposed to a six-hour anaesthetic 
(midazolam, isoflurane, and nitrous oxide) did not 
exhibit functional impairment or aggravated neuronal 
death. Sixty-day old (P60) rats exposed to isoflurane 
exhibited both increased neuronal differentiation and 
improved neurocognitive function.16
(9)  Painful stimuli may ameliorate AADN. It has been 
hypothesis’ed that painful stimuli may prevent the toxic 
effects of anaesthetics.2,25 In neonatal rats, pain results 
in neuronal excitation and cell death: this response is 
blocked by ketamine24 but not sevoflurane.10,30 
Human AADN studies: the evidence
‘… the cumulative data suggest a small increase in the risk of 
adverse neurodevelopmental outcome with exposure to 
anaesthesia and surgery … impairments in cognition or 
behaviour … the risk increases with increased cumulative 
exposure to anaesthesia and surgery.’2
The available human studies are précised in Table 2 with their 
essential findings delineated below.
(1)  In one form or another, this debate has been around for 
considerable time, early studies either being ignored or 
attributing postoperative behavioural changes solely to 
psychological stress.32,33
(2)  Behavioural disturbances similar to post-traumatic stress 
disorder occur in approximately 20% of children younger 
than 2 to 3½ years of age following the psychological 
trauma associated with anaesthesia, surgery and 
hospitalisation. Kotiniemi and colleagues’ study 
emphasised that behavioural response to such trauma 
varies widely.34 This negative behaviour is however self-
limiting, the majority of improvements occurring within 
the four weeks following surgery.32,34−42 
(3)  Multiple anaesthesia-surgical exposures at younger ages 
may increase the risk of subsequent learning disabilities.41,43
(4)  Brief anaesthesia exposure, including maternal exposure 
during labour and birth, does not affect the incidence of 
subsequent learning disabilities.47−51
(5)  Divergent effects on cognitive performance have been 
reported. Some studies show few or no consequences 
following early anaesthesia exposure, rather attributing 
all cognitive changes to genetics.47
(6)  Neurodevelopmental impairment does occur in children 
who survive severe life-threatening illnesses.52
Human AADN studies: critical evaluation
‘The clinical data, comprising largely retrospective cohort 
database analyses, are (concerning but) inconclusive, in part 
due to confounding variables inherent in these observational 
epidemiological approaches.’2
Given the limitations of these observational studies, it is difficult 
to draw any firm conclusions. At best, they suggest that an 
association between anaesthesia exposure and adverse outcome 
is possible. This uncertainty emphasises the need for further 
high-quality studies.
(1)  Viewpoints on the aetiological mechanisms of AADN are 
constantly changing. Older perspectives that postoperative 
changes were exclusively due to psychological trauma 
have radically shifted with recent experimental evidence 
Table 1: Definitions of the core pathophysiological concepts
Neurogenesis: The generation and survival of new-born neurons from neural stem/progenitor cells.21 
Synaptogenesis: The process of brain development that involves both neuronal development (migration, cell differentiation, synapse formation and axonal myelina-
tion) and apoptosis.66 In humans, synaptogenesis occurs between 28 weeks gestation and 4 years of age.128
Apoptosis: The process of selective neuronal suicide, an essential physiological process aimed at disposing of the 50% to 70% of redundant neurons produced during 
synaptogenesis.66
Neurotoxicity: The structural or functional alteration of the nervous system as a result of chemical, biological or physical agent exposure.129
Discordant: Where only one twin received an anaesthetic.
Learning disabilities: The need for individualised education, learning disability or impaired cognition. Other definitions and outcomes do, however, exist.
Southern African Journal of Anaesthesia and Analgesia 2016; 22(1):10-1812
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of the adverse impact of anaesthetics on cellular 
neurodevelopment. AADN is likely to have a multifactorial 
aetiology with genetic aberrations, prematurity and low 
birth weight, younger age, comorbid diseases, physiological 
Table 2: Human studies
1. Wilder et al. Early exposure to anaesthesia and learning disabilities in a population-based birth cohort. Anaesthesiology, 2009: This Mayo Clinic-based group 
interrogated medical and educational records contained in the Olmstead County Birth Cohort registry 19 years after children had been exposed to anaesthesia and 
surgery before 4 years of age.44 They concluded that not single, but rather two or more, exposures were associated with an increased risk (hazard ratios of 1.0, 1.59 and 
2.6) of subsequent reading, writing, and mathematical learning disabilities.
2. Flick et al. Cognitive and behavioural outcomes after early exposure to anaesthesia and surgery. Paediatrics, 2011: The Mayo Clinic group also compared the 
records of individuals 19 years after they had undergone surgery before age 2 years; the control group comprised unexposed individuals.45 Multiple but not single 
exposure was associated with greater learning disability and impaired cognition, the incidences being similar to those observed in the Wilder study.
3. DiMaggio et al. Early childhood exposure to anaesthesia and risk of developmental and Behavioural disorders in a sibling birth cohort. Anesth Analg, 2011: 
These investigators evaluated the effects of anaesthesia and surgery below 3 years of age on subsequent developmental and behavioural disorders. For exposure to 
one, two and three or more operations, the hazard ratio for developmental and behavioural disorders increased from 1.1 to 2.9 and 4.0 respectively.41
4. Stratmann et al. Effect of general anaesthesia in infancy on long-term recognition memory in humans and rats. Neuropsychopharmacology, 2014: Stratmann 
and colleagues performed a ‘parallel’ study, investigating both humans and rats. They concluded that early anaesthetic exposure deleteriously affected both humans 
and rats as demonstrated by impaired memory recollection tests.43
5. Bartels et al. Anaesthesia and cognitive performance in children: no evidence for a causal relationship. Twin Research and Human Genetics, 2009: This 
study enrolled monozygotic twins to differentiate the effects of genetics and anaesthetic exposure. At age 12 years, similar educational achievement and cognitive 
performance was noted in discordant twin pairs.47 This underpowered study observed no relationship between early anaesthesia exposure and subsequent cognitive 
performance.
6. Levy DM. Psychic trauma of operations in children. Am J Dis Child, 1945. This aptly titled study documented abnormal postoperative behaviour in 20% of 
children. Postoperative emotional consequences were analogous to combat neurosis, or post-traumatic stress disorder. He recommended that, where possible, 
surgery be postponed until after 3 years of age, and trauma be minimised with preoperative explanations, adequate premedication and maternal contact up to and 
immediately after surgery.
7. Eckenhoff. Relationship of anaesthesia to postoperative personality changes in children. Am J Dis Child, 1953: Using a parental questionnaire, this research-
er identified a 17% incidence of personality changes in children after ENT surgery.35 The findings paralleled those of Levy in that factors aggravating the changes 
included children younger than 3 years and psychological trauma (inadequate premedication, unsatisfactory induction with crying, struggling, vomiting and early 
airway obstruction). While the anaesthetics used (cyclopropane, ethylchloride and vinyl ether) in both this and Levy’s 1945 study are irrelevant to the effects of current 
anaesthetics on neurodevelopmental outcome, the conclusions are still valid.
8. Keaney et al. Postoperative behavioural changes following anaesthesia with sevoflurane. Paediatr Anaesth, 2004. Comparison of sevoflurane and halothane 
found, as expected, that the newer agent was associated with more emergence delirium.36,130,131 The negative postoperative behaviour decreased over time,34 and 
was not anaesthetic agent specific. This study is considered significant collateral evidence that modern drugs like sevoflurane are safe and cause minimal neuronal 
changes in both rodents,15,58 and in humans.65
9. Kotiniemi et al. Behavioural changes following routine ENT operations in two-to-ten-year-old children. Paediatr Anaesth, 1996: This was a study to detect 
personality changes following ENT surgery and not to detect potential anaesthesia-related problems.37 Age less than 3½ years was associated with more postopera-
tive behavioural problems; however, behaviour and sleeping patterns improved in a third of children, presumably due to correction of the underlying medical prob-
lem. This study also compared the effects on behaviour of one or two nights’ hospitalisation with the presence of parents with treatment as day case surgery. Despite 
large inter-individual differences in behavioural responses, no differences between the hospitalised and day cases were detected.
10. Kotiniemi et al. Behavioural changes in children following day-case surgery: a 4-week follow-up of 551 children. Anaesthesia, 1997: In this Finnish study, 
parents indicated that 47% of children exhibited negative behaviour following day surgery, these changes ordinarily resolving by 4 weeks.34 Negative behaviour was 
aggravated by poorly controlled pain on the first postoperative day, younger age and previous poor health care experience; anaesthetic technique did not account for 
any of the changes. The positive behavioural changes observed in 17% of children were associated with correction of an underlying medical condition.
11. DiMaggio et al. A retrospective cohort study of the association of anaesthesia and hernia repair surgery with Behavioural and developmental disorders in 
young children. J Neurosurg Anaesthesiol. 2009: Interrogation of New York Medicaid archives revealed more behavioural problems and developmental disorders 
subsequent to hernia repair before 3 years of age.57
12. Kalkman et al. Behaviour and development in children and age at the time of first anaesthetic exposure. Anaesthesiology, 2009: More behavioural abnor-
malities were observed if children underwent anaesthesia and surgery before rather than after 24 months of age.42
13. Hinz et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotising enterocolitis. Paediatrics, 2005:52 The infants 
with necrotising enterocolitis managed surgically rather than medically were significantly more likely to have specific (cerebral palsy, blindness, deafness) and global 
neurodevelopmental impairment. The poorer surgical group outcomes were likely a marker of the severity of the disease process.
14. Sprung et al. Anaesthesia for caesarean delivery and learning disabilities in a population-based birth cohort. Anaesthesiology, 2009: The Mayo Clinic group 
studied the association between general and regional anaesthesia during caesarean delivery and subsequent learning disabilities compared with vaginal delivery 
using the Olmstead County Birth Cohort registry.48 Sprung and colleagues concluded that the type of caesarean anaesthesia did not adversely affect long-term neu-
rodevelopmental outcomes.
15. Flick et al. Neuraxial labour analgesia for vaginal delivery and its effects on childhood learning disabilities. Anaesth Analg, 2011: Sprung and colleagues’ 
2009 study48 unexpectedly indicated a lower risk of learning disability occurred following caesarean section using neuraxial anaesthesia than normal vaginal deliv-
ery.48 The authors hypothesised this was due to less feto-maternal stress with neuraxial anaesthesia. A subsequent study by the same group found that neuraxial 
analgesia during labour was not associated with subsequent learning disabilities.49
16. Hansen et al. Academic performance in adolescence after inguinal hernia repair in infancy: a nationwide cohort study. Anaesthesiology, 2011: The academ-
ic performance of all Danish children undergoing inguinal hernia repair over a five-year period was compared with a randomly selected, matched population sample. 
After adjusting for congenital abnormalities and socio-economic differences, short-term anaesthesia exposure was not linked to later poorer academic performance.51
17. Ing et al. Long-term differences in language and cognitive function after childhood exposure to anaesthesia. Paediatrics 2012; 130, e476–85: These re-
searchers analysed 2 868 children who were enrolled in the Western Australian Pregnancy Cohort Study. Anaesthesia exposure before age 3 years was associated with 
increased risk of disability in language and cognition (abstract reasoning deficit) at age 10. The effects of anaesthesia on neuropsychological outcome may be limited 
to specific functional areas.
18. Block et al. Are anaesthesia and surgery during infancy associated with altered academic performance during childhood? Anaesthesiology 2012; 117: 494–
503: These investigators observed that anaesthesia-surgery during infancy was associated with worse academic achievement compared with the population norm.
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anaesthesia was more likely performed in emergency 
caesarean sections with neonates having lower 
gestational ages, birthweights and APGAR scores;48 the 
incidence of perinatal hypoxia was not noted in the 
DiMaggio study.57
(10)  The nature of the procedures, particularly that a large 
proportion were for otorhinolaryngeal procedures, may 
have biased the conclusions and results of some of the 
retrospective studies. The need for tympanostomy 
tubes has been linked to delayed language development, 
this measurement being an important endpoint of 
AADN studies.31
(11)  It is obviously not ethically acceptable to anaesthetise 
neonates solely to interrogate the effects thereof.2 This 
ethical consideration has been addressed by studying 
AADN using retrospective observational clinical studies. 
Unfortunately, these studies have multiple 
problems.1,42,44,47,48,57,66 The results of the first randomised 
controlled human trial, the GAS study, are therefore eagerly 
awaited.
Human AADN studies currently being 
conducted
‘The lack of robust clinical evidence ‘places even greater 
emphasis on prospective approaches to this problem, such 
as the ongoing GAS trial and PANDA study’.’2
(1)  ‘SAFEKIDS’ and SMART-Tots: Unresolved concerns with 
the available research prompted the US Food and Drug 
Administration (FDA) to launch a clinical research 
initiative entitled ‘Safety of Key Inhaled and Intravenous 
Drugs in Paediatrics’ (‘SAFEKIDS’). SAFEKIDS evolved into 
a private–public partnership between the FDA and the 
International Anaesthesia Research Society (IARS) 
entitled ‘Strategies for Mitigating Anaesthesia-Related 
Toxicity in Tots’ (SMART-Tots). The SMART-Tots website 
indicates that the collaboration is currently funding 
research in non-human primates by the National Centre 
for Toxicological Research and has awarded generous 
grants for several multicentre human trials.
(2)  PANDA: The ‘Paediatric Anaesthesia NeuroDevelopment 
Assessment’ (PANDA) study (http://www.clinicaltrials.
gov/ct2/show/NCT00754897) has enrolled 500 sibling 
pairs discordant for inguinal hernia surgery under general 
anaesthesia before age 36 months and data are currently 
being analysed. Long-term effects of anaesthesia on 
neurodevelopment will be evaluated.1,77,78
(3)  GAS: The GAS study (A Multi-site Randomised Controlled Trial 
Comparing Regional and General Anaesthesia for Effects on 
Neurodevelopmental Outcome and Apnea in Infants; 
http://www.clinicaltrials.gov/ct2/show/NCT00756600) is a 
seven-country international randomised control trial aimed 
at determining whether impaired outcome after surgery can 
be attributed to general anaesthetic agents rather than 
effects of prematurity, illness or the surgical intervention 
itself.78 Following general or regional anaesthesia alone (no 
sedation at all in the regional group) for hernia repair, 
neurodevelopmental outcome will be performed at 2 and 
again at 5 years of age. The earlier assessment with Bayley 
Scales for Infant Development is a secondary outcome of this 
trespass, psychological stress, and anaesthetics all 
contributing.44 Healthy children are less likely to require 
multiple anaesthetics and procedures. Is it the presence of 
co-morbid disease that adversely affects children’s 
learning opportunities and alters parents’ psyche?
(2)  Surgically induced inflammation and the associated 
cytokine response, which has been associated with 
blood–brain barrier and neurological changes in adults, 
may also contribute to the problem.14,53
(3)  A serious concern is that no human study has as yet 
considered the role of perioperative-altered physiology 
(hypoxia, hypotension, low cardiac output, hypercarbia, 
hypoglycaemia) as a contributor to AADN. An explicit 
criticism of the Wilder study is that it was performed 
between 1976 and 1982, a time before both routine 
pulse oximetry and ASA minimum monitoring standards 
became mandatory.50,54
(4)  The relative contributions of aetiological factors in 
points 1 to 3 above are difficult to quantify.40 It may also 
be that the direct neurotoxic effects of anaesthetics are 
relatively minor compared with points 1 to 3 above.54−56
(5)  The role that particular anaesthetics play in AADN is not 
known. What has been suggested is that modern agents 
such as sevoflurane are safer,57 causing minimal 
neuronal changes in vitro, in rodents8,15,26,58−64 and in 
humans.65 These findings suggest that studies which 
employed outdated anaesthesia agents (halothane, 
enflurane, methoxyflurane, nitrous oxide) are less 
relevant to current practice.44,48,66 Nonetheless, recent 
research contradicts these findings and suggests that 
sevoflurane has similar toxicity9,30,67−72 while a single 
study suggested that desflurane61 induced worse 
neuroapoptosis than other anaesthetics.
(6)  Despite dose-dependent and duration-dependent 
deleterious neurocognitive effects being identified in 
animal studies, no study has considered the effects of 
either anaesthetic duration or anaesthetic depth.73 
While brief anaesthetic exposure is unlikely to produce 
long-term learning disability,51,74 the aforementioned 
concerns may be relevant considering that excessive 
anaesthesia depth is associated with postoperative 
cognitive dysfunction in the elderly.75 There may be 
similarities/overlap between AADN in very young and 
elderly brains.23,27,76
(7)  Whether studies can be extrapolated to other population 
groups is not known. The Wilder study population has 
been critiqued for having studied a homogeneous white 
middle-class cohort.
(8)  The evaluation of neurodevelopmental impairment has 
been neither free of bias nor comparable between 
studies. Examples of such methodological inconsistencies 
include the Wilder study that interrogated learning 
outcomes and not disabilities,44 possible parental bias 
when answering questionnaires,42 and that diagnosis of 
behavioural disorders in young children is susceptible to 
selection bias and misclassification.
(9)  Some studies may have enrolled sicker patients. 
Examples include the Sprung study where general 
Southern African Journal of Anaesthesia and Analgesia 2016; 22(1):10-1814
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uncertainty caused by the currently available research and, 
second, ‘what can reasonably be learned from continuing to 
analyse existing data sources is becoming increasingly limited’.40
Possible cellular mechanisms of AADN
‘Since exposure to GAs often cannot be avoided when a 
child’s well-being is in danger, a considerable effort has been 
made in recent years to elucidate the mechanisms of 
anaesthesia-induced developmental neuroapoptosis.’27
Current research is attempting to elucidate the subcellular, non-
anaesthetic AADN mechanisms; detailed knowledge thereof 
may facilitate development of preventative measures.21,23 Despite 
significant overlap between AADN-related mechanisms, the 
main themes involve anaesthesia-induced calcium dysregulation, 
accelerated neuroapoptosis, altered neurogenesis, 
teratogenicity, neuroexcitation, and inflammation.
Anaesthetic-induced neuronal and mitochondrial calcium 
dysregulation likely has multiple underlying mechanisms, 
including:81,82
(1)  anaesthetic activation of agonist- (NMDA) and voltage-
dependent calcium channels;83
(2)  isoflurane activation of GABA-A receptors leads to 
chloride efflux, neuronal membrane depolarisation and 
opening of voltage-dependent calcium channels. This 
has been termed the ‘reversed transmembrane chloride 
gradient’;84 and
(3)  isoflurane, sevoflurane, desflurane and propofol all 
activate inositol triphosphate receptors, which stimulates 
calcium-induced calcium release (CICR) from the 
endoplasmic reticulum.84
Intracellular calcium overload damages intracellular organelles, 
particularly mitochondria, endoplasmic reticulum and 
lysosomes. Increased cytosolic calcium increases lysosomal 
activity and accelerates autophagy.85 Endoplasmic reticulum 
damage inhibits protein synthesis and impairs neuronal growth 
and repair.81,86
Anaesthetic agents also cause mitochondrial calcium overload. 
The consequent mitochondrial injury is revealed histologically as 
organelle enlargement, compromised structural integrity and 
reduced organelle density, and functionally as impaired ATP 
production.78 Mitochondrial damage is also a potent activator of 
the intrinsic apoptotic pathway.86 Elevated mitochondrial 
calcium concentrations abolish the normal mitochondrial 
transmembrane potential, and greatly increase mitochondrial 
permeability transition pore activity, with cytosolic translocation 
of cytochrome C, a potent activator of the intrinsic apoptotic 
pathway. Increased mitochondrial calcium concentrations also 
activate certain proteins within the mitochondria that activate 
the intrinsic apoptotic pathway.86
Accelerated apoptosis of neurons that would normally survive 
was formerly considered the crucial AADN mechanism,5,87 
Neuroapoptosis may be initiated via one of two discrete (intrinsic 
or extrinsic) pathways.2,14,88 Elevated cytosolic calcium activates 
calpain, a calcium-dependent protease, which initiates the 
intrinsic apoptotic pathway neuroapoptosis.89,90 Other 
mechanisms activating the intrinsic apoptotic pathway are 
mitochondrial damage (see above) and neurotrophic hypothesis. 
study. The later assessment, a primary outcome of this study, 
will use the Wechsler Preschool and Primary Scale of 
Intelligence Third Edition Full Scale Intelligence Quotient and 
additional neuropsychological tests within NEPSY II (Second 
edition of the neuropsychological test battery for children 
and adolescents).1 Recruitment is complete and the 5 year 
follow-up will be completed in 2017.23
Preliminary findings showed significant differences in 
mean arterial pressures between the general anaesthesia 
and spinal groups, general anaesthesia having lower 
intraoperative blood pressures. Differences in apnoea 
rates on arrival in recovery were also identified between 
the two groups, this latter finding prompting a new study 
of perioperative NIRS monitoring in children under 
6 months undergoing general anaesthesia.79 GAS study 
secondary outcomes were very recently (October 24, 
2015) made available online on the Lancet website. 
Results were analysed for 238 of 363 and 294 of 359 
infants administered awake regional and general 
anaesthesia respectively. Despite the difference in the 
preliminarily results, cognitive scores did not differ at all. 
The authors concluded, ‘For this secondary outcome, we 
found no evidence that just less than 1 h of sevoflurane 
anaesthesia in infancy increases the risk of adverse 
neurodevelopmental outcome at 2  years of age 
compared with awake-regional anaesthesia’.
(4)  Danish study: An ongoing study is comparing the academic 
achievements of the Danish population with that of all 
children who underwent surgery between 1977 and 1990 
and were younger than 1 year of age at the time.50
Meta-analyses attempt to clarify the 
probability of AADN
‘Concerns over the effects of anaesthesia on the developing 
brain remain well placed; … The uncertainty with existent 
epidemiological evidence is considerable.’40
Three recent meta-analyses independently concluded that the 
associations between early anaesthetic exposure and adverse 
neurodevelopmental outcomes are tenuous due to the 
limitations inherent in current studies.2,40,80 Wang et al. observed 
an increased risk of adverse neurodevelopmental outcomes 
following multiple, early anaesthesia exposures. This meta-
analysis also indicated that following single exposure, anaesthetic 
dose and duration was not important.80 Sanders et al.’s meta-
analysis indicated only a small increase in AADN risk, this risk 
increasing with increased cumulative anaesthesia exposures.2
DiMaggio and colleagues performed a Bayesian meta-analysis of 
the current literature. Standard and Bayesian meta-analyses 
differ with the latter seeking to identify the odds ratio of the 
main endpoint, in this case AADN. DiMaggio and colleagues’ 
Bayesian meta-analysis calculated an AADN odds ratio and 95% 
credible interval of 2.0 and 0.7–4.7 respectively. These data were 
used to estimate that, for the USA, the population-attributable 
risk of an anaesthesia-related learning or a behavioural disorder 
was 2.6%. For comparison, the population-attributable risk of 
smoking-related cardiovascular disease approximates 10.9%. 
Their two main conclusions were, first, that ‘concerns over the 
effects of anaesthesia on the developing brain remain well 
placed’ despite the considerable variation in results and 
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stem cell loss and memory loss correlate well with each 
other.102
(7)  Glial cell cytosketetal damage: Isoflurane damages the 
cytoskeleton of immature astroglial cells.101
(8)  Teratogenicity: Anaesthetic administration to pregnant 
animals indicates that the foetus is at significant risk for 
AADN. For example, the offspring of halothane- or 
enflurane-exposed pregnant mice learn more slowly 
than controls and exhibit behavioural changes.105 Better 
understanding of inter-species neurodevelopmental 
timeframes is needed.28,47,105
Anaesthesia-induced neuroexcitation and convulsions have 
been observed following sevoflurane anaesthesia in rats.70,106 The 
implications of this observation are currently not clear.
Neuroprotection against AADN
‘Does the Emperor have no clothes?’55
The concept of employing neuroprotective agents for AADN has 
been extrapolated from strategies used in neuro- and cardiac 
surgery, traumatic brain injury and hypoxic ischaemic 
encephalopathy.26 Hypoxic ischaemic encephalopathy may be a 
more relevant model as the pathophysiology overlaps with that 
of AADN, as, in both, the predominant mechanism of injury is 
neuroapoptosis.107 Neuroprotectants are currently in the 
preclinical (animal research) stage. Human studies are still 
lacking. The possibilities are numerous:
(1)  Erythropoietin: Erythropoietin is used in neonatal 
encephalopathy.108−112 Its protective effects stem from 
its inhibition of the final common neuronal apoptosis 
pathway involving caspase-3 and also because it 
activates cell-survival signals.108−112 It has recently been 
shown to protect against neonatal rat sevoflurane 
neurotoxicity.113
(2)  Dexmedetomidine: Not only does high-dose 
dexmedetomidine not induce neuronal apoptosis,11 but 
it also attenuates isoflurane- and ketamine-induced 
apoptosis.10,11,114 This is interesting as alpha-2 
adrenoreceptors are involved in neurodevelopment, and 
also relevant as this class of drugs is used clinically in 
paediatric anaesthesia. Dexmedetomidine may possibly 
attenuate AADN even if administered post-insult.10,11,26,114
(3)  17B-Oestradiol: Oestradiol limits both NMDA-antagonist 
and GABAA-agonist induced murine neurotoxicity via 
activation of a pro-survival protein that limits apoptotic 
signalling.115 Its physiological role may be 
neuroprotection during delivery. Long-term 
administration may alter neuronal development.116
(4)  Xenon: Xenon is a peculiar NMDA antagonist. Although 
it has been implicated as pro-apoptotic in some studies, 
others have shown that it is neuroprotective and limits 
anaesthesia-related neuroapoptosis (Brosnan).88,117 It 
also limits ischemic-hypoxic encephalopathy induced 
neuroapoptosis,26,117 in this respect acting synergistically 
with both dexmedetomidine,118 and also hypothermia.119 
Xenon is exorbitantly expensive and not freely available 
for clinical use.
(5)  Melatonin: Melatonin stabilises mitochondria and 
reduces the release of caspase-9 and cytochrome-C. 
This latter hypothesis suggests that the anaesthesia-induced 
interruption of sustained (neurotrophic) neuronal synaptic 
activity leads to postsynaptic neurons deeming they are 
redundant with initiation of intrinsic apoptosis.2,91,92 It has been 
suggested that surgical stimulation may counteract this ‘use it or 
loose it’ mechanism.55,78 Extrinsic apoptotic pathway activation 
typically follows external stimuli such as inflammation with 
associated tumour necrosis factor release. It is of relevance that, 
as opposed to their anti-inflammatory effects in adults, 
anaesthetics promote inflammation in children. Furthermore, 
isoflurane activates the neurotrophin receptor that initiates actin 
depolymerisation, causing synaptic loss and accelerated 
neuronal apoptosis.93
Developmental delays and altered neurogenesis have recently 
also been observed in the absence of accelerated apoptosis.2,94 In 
this respect, multiple cellular vulnerabilities exist where 
anaesthetics may interfere with neurogenesis:83,85,93−102
(1)  Anaesthesia-induced impaired calcium oscillation: Well-
ordered calcium oscillation is important in normal neural 
developmental processes such as gene expression, 
synaptogenesis, differentiation, axonal growth, and 
dendritic arborisation.83
(2)  Delayed axon polarisation: Axon polarisation is a critical 
development process whereby neurons develop axon- 
and dendrite-specific components. This process is 
delayed by both isoflurane and propofol.95
(3)  Impaired dendritic spine development: Dendritic spines 
are protrusions on neuronal dendrites that receive and 
transmit synaptic signals. Systematic dendritic spine 
development and activity are essential for normal 
synaptogenesis and normal neuronal circuit assembly.97 
Dissimilar anaesthetics affect dendritic spine 
development differently. Modern volatile agents 
(sevoflurane, desflurane) increase, whereas ketamine 
consistently reduces, dendritic spine density 
respectively.103 Propofol’s effect depends on the 
developmental stage, decreases and increases in 
dendritic spine density occurring in younger and older 
neonatal rats respectively.98
(4)  Brain-derived neurotrophic factor (BDNF): BDNF either 
promotes survival or accelerates neuronal apoptosis, 
depending on its arrangement. BDNF is secreted from 
neurons as proneurotrophin (proBDNF). Neuronal activity 
causes release of tissue plasminogen activator, which 
cleaves plasminogen to plasmin. In turn, plasmin cleaves 
proBDNF to BDNF, the latter promoting synaptogenesis 
and neuronal survival. Anaesthetic inhibition of neuronal 
activity is accompanied by less release of tissue 
plasminogen and less plasmin formation. This fosters 
dominance of proBDNF, which impairs synaptogenesis 
and accelerates neuroapoptosis.2,99 The possibility of 
pharmacologically influencing BDNF expression to favour 
cell survival to ameliorate AADN has been mooted.14,88,99,104
(5)  Impairment of neural precursor (progenitor) cell 
proliferation: Isoflurane reduces proliferation of neural 
precursor cells in the rat hippocampus.100
(6)  Stem cell loss: Isoflurane-exposed infant rats had a 
reduced pool of hippocampal stem cells; the extents of 
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Approach for clinicians
‘It is unlikely that definitive clinical studies absolving general 
anaesthetics of neurotoxicity will become available in the near 
future, requiring clinicians to use careful judgement when using 
these profound neurodepressants in vulnerable patients.’23
As anaesthesia safety progresses, minor concerns increase in 
importance. In this respect, the likening of anaesthesia to sleep 
suggests a fully reversible condition with no long-term adverse 
sequelae: unfortunately this may not be true. Clinicians are in a 
difficult position, needing to weigh the risks of surgery and 
AADN despite the current lack of consensus and firm evidence. 
These concerns must be communicated to parents, surgical and 
medical colleagues in a clear, non-anxiety-provoking manner. 
This latter overtly simple instruction is a difficult brief, facilitated 
by practitioners keeping up to date with current study findings 
and expert opinions. Advice could follow the following path:
(1)  No data currently support delaying surgery.
(1.1)  Newer data show that one cannot define the time 
scale of the ‘brain growth spurt’ reliably.
(1.2)  One should be cognisant that very few procedures 
performed in young children are truly elective.
(2)  If surgery does proceed, the following points need 
consideration:
(2.1)  Modern surgery cannot be separated from 
anaesthesia for practical and humane reasons.11,15 
Indeed, well-conducted anaesthesia and effective 
postoperative analgesia will likely minimise a child’s 
psychological trauma.
(2.2)  In medicine, benefits are often associated with some 
degree of risk. The gains likely to be achieved by 
treating a surgically correctable problem must be 
weighed against risks of anaesthesia. The latter risks 
include the largely unproven entity of human AADN.
(2.3)  Single anaesthetics-surgeries appear safe. It is perhaps 
reassuring that a single ‘brief’ anaesthetic exposure 
does not appear to harm the developing brain.50,51
(2.4)  If multiple procedures are likely to be needed, 
unnecessary delays may compromise the future well-
being of the child leaving little choice but to continue.
(3)  Anaesthesia practice: If surgery does proceed, 
anaesthesiologists must adopt a non-reactive, measured 
approach. Currently, the United States Food and Drug 
Administration (FDA) also agrees there is no evidence to 
suggest changes in anaesthetic practice or omitting 
particular anaesthetic agents, almost all anaesthetic 
agents having been implicated in AADN.127 Attention 
needs to be given to maintenance of physiological 
homeostasis. Meticulous record keeping is of utmost 
importance.
References
1.  Sun L. Early childhood general anaesthesia exposure and 
neurocognitive development. Br J Anaesth. 2010 Dec;105(Suppl 
1):i61–8.
2.  Sanders RD, Hassell J, Davidson AJ, et al. Impact of anaesthetics 
and surgery on neurodevelopment: an update. Br J Anaesth. 2013 
Jun;110(Suppl 1):i53–72.
Melatonin’s actions are dose dependent with 1 and 
20  mg/kg limiting anaesthesia-induced apoptosis by 
30–40% and 75–90% respectively.26,82 Its favourable 
side effect profile and hypnotic and analgesic properties 
make melatonin a strategically useful drug that would 
potentially target AADN. Human studies are still 
outstanding.
(6)  Lithium: Propofol and NMDA antagonists suppress 
extracellular signal regulated protein kinase (ERK) 
phosphorylation.120 Lithium counteracts this with 
reversal of both propofol- and ketamine-induced 
neuroapoptosis.120 Lithium’s side effect profile limits its 
use in paediatric anaesthesia.
(7)  Free radical scavengers: Apoptosis is associated with 
the mitochondrial electron transport chain upregulating 
its production of reactive oxygen species.121 Free radical 
scavengers and anti-oxidants protect the mitochondria 
from such damage.122,123
(8)  Omega-3-polyunsaturated fatty acids: Supplementing 
the diets of pregnant rats with fish oil ameliorated the 
deleterious effects caused by neonatal sevoflurane 
exposure.124
(9)  Bumetanide: In neonatal rats, prior treatment with the 
Na-K-Cl cotransporter inhibitor, bumetanide, was 
effective in inhibiting the deleterious neuroBehavioural 
effects of sevoflurane but not isoflurane.70
(10)  Avoiding hypnotic anaesthetics: A recent editorial 
suggested that the concept of anaesthesia (immobility, 
analgesia and lack of recall) is not relevant in neonates, 
and that large doses of opioids alone would suffice.55
Perspective on neuroprotective agents
The wisdom of administering drugs with unknown toxicity to 
protect from a hypothetical condition is questionable. It has 
been suggested that the therapeutic benefits and neurotoxic 
side effects of neuroprotective drugs could be inseparable 
companions. The explanation offered is that general anaesthetics 
are neuroprotective during (focal) brain ischaemia because they 
decrease metabolic demands and limit excitotoxicity. However, 
the more effective an agent is at suppressing neuronal activity, 
the more likely it may cause apoptosis of developing neurons. 
Indeed, there appears to be a fine homeostatic balance between 
pro-apoptotic and pro-survival proteins in the brain. In an 
interesting study, Milanovic and colleagues demonstrated that 
in neonatal rat brains exposed to propofol, the increase in 
apoptotic proteins was accompanied by a concomitant increase 
in pro-survival proteins.125
Non-pharmacological therapy
The hypothesis suggests that employing neuroplasticity 
constructively may ameliorate the toxic effects of anaesthetics.126 
The concept is exemplified by studies demonstrating that short-
term memory impairment following murine sevoflurane 
exposure was reversed by ‘immediate’ or ‘delayed’ environmental 
enrichment.30 Environmental enrichment consists of voluntary 
exercise, social interaction and increased environmental 
complexity. The process possibly re-engages neurons that would 
otherwise undergo post-anaesthesia apoptosis. A significant 
advantage of this technique is that it does not incur additional 
pharmacological risks.126 Human reports employing such 
therapeutic strategies have as yet not been published.
Anaesthesia associated developmental neurotoxicity (AADN) 2015 17
The page number in the footer is not for bibliographic referencingwww.tandfonline.com/ojaa 17
Anaesthesia associated developmental neurotoxicity (AADN) 2015 12
the young mammalian brain. Ann N Y Acad Sci. 2010 Jun;1199:43–51.
74.  Cottrell JE, Hartung J. Developmental disability in the young and 
postoperative cognitive dysfunction in the elderly after anaesthesia 
and surgery: do data justify changing clinical practice? Mt Sinai J 
Med. 2012 Jan-Feb;79(1):75–94.
75.  Avidan MS, Evers AS. Review of clinical evidence for persistent 
cognitive decline or incident dementia attributable to surgery or 
general anaesthesia. J Alzheimers Dis. 2011;24(2):201–16.
76.  Jevtovic-Todorovic V. Functional implications of an early exposure to 
general Anaesthesia: are we changing the behaviour of our children? 
Mol Neurobiol. 2013 Oct;48(2):288–93.
77.  Sun LS, Li G, DiMaggio CJ, et al. Feasibility and pilot study of the 
paediatric anaesthesia neurodevelopment assessment (PANDA) 
project. J Neurosurg Anaesthesiol. 2012 Oct;24(4):382–8.
78.  Davidson AJ. Anaesthesia and neurotoxicity to the developing brain: 
the clinical relevance. Paediatr Anaesth. 2011 Jul;21(7):716–21.
79.  Davidson AJ, Morton NS, Arnup SJ, et al. Apnea after awake regional 
and general anaesthesia in infants: the general Anaesthesia 
compared to spinal anaesthesia study-comparing apnea and 
neurodevelopmental outcomes, a randomized controlled trial. 
Anaesthesiology. 2015 May 14:[Epub ahead of print].
80.  Wang M, Zhang JH, Applegate RL 2nd. Adverse effect of inhalational 
anaesthetics on the developing brain. Med Gas Res. 2014;4(1):2.
81.  Wei H. The role of calcium dysregulation in Anaesthetic-mediated 
neurotoxicity. Anesth Analg. 2011 Nov;113(5):972–4.
82.  Yon JH, Carter LB, Reiter RJ, et al. Melatonin reduces the severity 
of Anaesthesia-induced apoptotic neurodegeneration in the 
developing rat brain. Neurobiol Dis. 2006 Mar;21(3):522–30.
83.  Sinner B, Friedrich O, Zink W, et al. The toxic effects of s(+)-ketamine 
on differentiating neurons in vitro as a consequence of suppressed 
neuronal Ca2+ oscillations. Anaesth Analg. 2011 Nov;113(5):1161–9.
84.  Zhao YL, Xiang Q, Shi QY, et al. GABAergic excitotoxicity injury of the 
immature hippocampal pyramidal neurons' exposure to isoflurane. 
Anesth Analg. 2011 Nov;113(5):1152–60.
85.  Sanchez V, Feinstein SD, Lunardi N, et al. General Anaesthesia 
causes long-term impairment of mitochondrial morphogenesis and 
synaptic transmission in developing rat brain. Anaesthesiology. 2011 
Nov;115(5):992–1002.
86.  Jevtovic-Todorovic V, Boscolo A, Sanchez V, et al. Anaesthesia-induced 
developmental neurodegeneration: the role of neuronal organelles. 
Front Neurol. 2012;3:141.
87.  Jevtovic-Todorovic V. Good gas, bad gas: isoflurane, carbon monoxide, 
and which is which? Anaesth Analg. 2014 Jun;118(6):1160–2.
88.  Ma D, Williamson P, Januszewski A, et al. Xenon mitigates isoflurane-
induced neuronal apoptosis in the developing rodent brain. 
Anaesthesiology. 2007 Apr;106(4):746–53.
89.  Inan S, Wei H. The cytoprotective effects of dantrolene: a ryanodine 
receptor antagonist. Anesth Analg. 2010 Dec;111(6):1400–10.
90.  Momeni HR. Role of calpain in apoptosis. Cell J (Yakhteh). 2011 
Summer;13(2):65–72.
91.  Olney JW, Young C, Wozniak DF, et al. Anaesthesia-induced 
developmental neuroapoptosis. Does it happen in humans? 
Anaesthesiology. 2004 Aug;101(2):273–5.
92.  Franks NP. General anaesthesia: from molecular targets to neuronal 
pathways of sleep and arousal. Nat Rev Neurosci. 2008 May;9(5):370–86.
93.  Lemkuil BP, Head BP, Pearn ML, et al. Isoflurane neurotoxicity is 
mediated by p75NTR-RhoA activation and actin depolymerisation. 
Anaesthesiology. 2011 Jan;114(1):49–57.
94.  Wagner M, Ryu YK, Smith SC, et al. Review: effects of Anaesthetics on 
brain circuit formation. J Neurosurg Anaesthesiol. 2014 Oct;26(4):358–
62.
95.  Mintz CD, Smith SC, Barrett KM, et al. Anaesthetics interfere with 
the polarization of developing cortical neurons. J Neurosurg 
Anaesthesiol. 2012 Oct;24(4):368–75.
96.  Mintz CD, Wagner M, Loepke AW. Preclinical research into the effects 
of anaesthetics on the developing brain: promises and pitfalls. J 
Neurosurg Anaesthesiol. 2012 Oct;24(4):362–7.
97.  Briner A, De Roo M, Dayer A, et al. Volatile Anaesthetics rapidly 
increase dendritic spine density in the rat medial prefrontal cortex 
during synaptogenesis. Anaesthesiology. 2010 Mar;112(3):546–56.
98.  Briner A, Nikonenko I, De Roo M, et al. Developmental stage-
dependent persistent impact of propofol Anaesthesia on dendritic 
51.  Hansen TG, Pedersen JK, Henneberg SW, et al. Academic performance 
in adolescence after inguinal hernia repair in infancy: a nationwide 
cohort study. Anaesthesiology. 2011 May;114(5):1076–85.
52.  Hintz SR, Kendrick DE, Stoll BJ, et al. Neurodevelopmental and growth 
outcomes of extremely low birth weight infants after necrotising 
enterocolitis. Paediatrics. 2005 Mar;115(3):696–703.
53.  Wan Y, Xu J, Ma D, et al. Postoperative impairment of cognitive 
function in rats: a possible role for cytokine-mediated inflammation 
in the hippocampus. Anaesthesiology. 2007 Mar;106(3):436–43.
54.  Wu B, Yu Z, You S, et al. Physiological disturbance may contribute to 
neurodegeneration induced by isoflurane or sevoflurane in 14 day 
old rats. PLoS One. 2014;9(1):e84622.
55.  Davidson AJ. Neurotoxicity and the need for anaesthesia in the 
newborn: does the emperor have no clothes? Anaesthesiology. 2012 
Mar;116(3):507–9.
56.  Stratmann G, May LD, Sall JW, et al. Effect of hypercarbia and isoflurane 
on brain cell death and neurocognitive dysfunction in 7-day-old rats. 
Anaesthesiology. 2009 Apr;110(4):849–61.
57.  DiMaggio C, Sun LS, Kakavouli A, et al. A retrospective cohort study 
of the association of Anaesthesia and hernia repair surgery with 
Behavioural and developmental disorders in young children. J 
Neurosurg Anaesthesiol. 2009 Oct;21(4):286–91.
58.  Wei H, Kang B, Wei W, et al. Isoflurane and sevoflurane affect 
cell survival and BCL-2/BAX ratio differently. Brain Res. 2005 Mar 
10;1037(1–2):139–47.
59.  Bercker S, Bert B, Bittigau P, et al. Neurodegeneration in newborn rats 
following propofol and sevoflurane anaesthesia. Neurotox Res. 2009 
Aug;16(2):140–7.
60.  Wang QJ, Li KZ, Yao SL, et al. Different effects of isoflurane 
and sevoflurane on cytotoxicity. Chin Med J (Engl). 2008 Feb 
20;121(4):341–6.
61.  Kodama M, Satoh Y, Otsubo Y, et al. Neonatal desflurane exposure 
induces more robust neuroapoptosis than do isoflurane and 
sevoflurane and impairs working memory. Anaesthesiology. 2011 
Nov;115(5):979–91.
62.  Callaway JK, Jones NC, Royse CF. Isoflurane induces cognitive deficits 
in the Morris water maze task in rats. Eur J Anaesthesiol. 2012 
May;29(5):239–45.
63.  Ramage TM, Chang FL, Shih J, et al. Distinct long-term neurocognitive 
outcomes after equipotent sevoflurane or isoflurane anaesthesia in 
immature rats. Br J Anaesth. 2013 Jun;110(Suppl 1):i39–46.
64.  Kilicaslan A, Belviranli M, et al. Single and repeated sevoflurane or 
desflurane exposure does not impair spatial memory performance of 
young adult mice. Fundam Clin Pharmacol. 2013 Dec;27(6):641–9.
65.  Matsuoka H, Kurosawa S, Horinouchi T, et al. Inhalation Anaesthetics 
induce apoptosis in normal peripheral lymphocytes in vitro. 
Anaesthesiology. 2001 Dec;95(6):1467–72.
66.  Loepke AW, Soriano SG. An assessment of the effects of general 
Anaesthetics on developing brain structure and neurocognitive 
function. Anaesth Analg. 2008 Jun;106(6):1681–707.
67.  Istaphanous GK, Howard J, Nan X, , et al. Comparison of the 
neuroapoptotic properties of equipotent Anaesthetic concentrations 
of desflurane, isoflurane, or sevoflurane in neonatal mice. 
Anaesthesiology. 2011 Mar;114(3):578–87.
68.  Shen X, Liu Y, Xu S, et al. Early life exposure to sevoflurane impairs 
adulthood spatial memory in the rat. NeuroToxicol. 2013 Dec;39:45–
56.
69.  Zheng SQ, An LX, Cheng X, et al. Sevoflurane causes neuronal 
apoptosis and adaptability changes of neonatal rats. Acta 
Anaesthesiol Scand. 2013 Oct;57(9):1167–74.
70.  Seubert CN, Zhu W, Pavlinec C, et al. Developmental effects of neonatal 
isoflurane and sevoflurane exposure in rats. Anaesthesiology. 2013 
Aug;119(2):358–64.
71.  Wang SQ, Fang F, Xue ZG, et al. Neonatal sevoflurane Anaesthesia 
induces long-term memory impairment and decreases hippocampal 
PSD-95 expression without neuronal loss. Eur Rev Med Pharmacol 
Sci. 2013 Apr;17(7):941–50.
72.  Fang F, Xue Z, Cang J. Sevoflurane exposure in 7-day-old rats affects 
neurogenesis, neurodegeneration and neurocognitive function. 
Neurosci Bull. 2012 Oct;28(5):499–508.
73.  Rizzi S, Ori C, Jevtovic-Todorovic V. Timing versus duration: 
determinants of anaesthesia-induced developmental apoptosis in 
Southern African Journal of Anaesthesia and Analgesia 2016; 22(1):10-1818
The page number in the footer is not for bibliographic referencingwww.tandfonline.com/ojaa 18
13 Southern African Journal of Anaesthesia and Analgesia 2016; 22(1):4–13
115.  Asimiadou S, Bittigau P, Felderhoff-Mueser U, et al. Protection with 
estradiol in developmental models of apoptotic neurodegeneration. 
Ann Neurol. 2005 Aug;58(2):266–76.
116.  Pytel M, Wojtowicz T, Mercik K, et al. 17 beta-estradiol modulates 
GABAergic synaptic transmission and tonic currents during 
development in vitro. Neuropharmacology. 2007 May;52(6):1342–
53.
117.  Shu Y, Patel SM, Pac-Soo C, et al. Xenon pretreatment attenuates 
anaesthetic-induced apoptosis in the developing brain in 
comparison with nitrous oxide and hypoxia. Anaesthesiology. 2010 
Aug;113(2):360–8.
118.  Rajakumaraswamy N, Ma D, Hossain M, et al. Neuroprotective 
interaction produced by xenon and dexmedetomidine on in 
vitro and in vivo neuronal injury models. Neurosci Lett. 2006 Dec 
1;409(2):128–33.
119.  Ma D, Sanders RD, Halder S, et al. Xenon exerts age-independent 
antinociception in fischer rats. Anaesthesiology. 2004 
May;100(5):1313–8.
120.  Straiko MM, Young C, Cattano D, et al. Lithium protects 
against anaesthesia-induced developmental neuroapoptosis. 
Anaesthesiology. 2009 Apr;110(4):862–8.
121.  Cadenas E, Davies KJ. Mitochondrial free radical generation, 
oxidative stress, and aging. Free Radic Biol Med. 2000 Aug;29(3–
4):222–30.
122.  Reiter PD, Pietras M, Dobyns EL. Prolonged dexmedetomidine 
infusions in critically ill infants and children. Indian Paediatr. 2009 
Sep;46(9):767–73.
123.  Braun S, Gaza N, Werdehausen R, et al. Ketamine induces apoptosis 
via the mitochondrial pathway in human lymphocytes and 
neuronal cells. Br J Anaesth. 2010 Sep;105(3):347–54.
124.  Lei X, Zhang W, Liu T, et al. Perinatal supplementation with omega-3 
polyunsaturated fatty acids improves sevoflurane-induced 
neurodegeneration and memory impairment in neonatal rats. PLoS 
One. 2013;8(8):e70645.
125.  Milanovic D, Pesic V, Popic J, et al. Propofol Anaesthesia induces 
proapoptotic tumor necrosis factor-alpha and pro-nerve growth 
factor signaling and prosurvival Akt and XIAP expression in 
neonatal rat brain. J Neurosci Res. 2014 Oct;92(10):1362–73.
126.  Jevtovic-Todorovic V. Anaesthesia and the developing brain: 
are we getting closer to understanding the truth? Curr Opinion 
Anaesthesiol. 2011 Aug;24(4):395–9.
127.  Mellon RD, Simone AF, Rappaport BA. Use of Anaesthetic agents in 
neonates and young children. Anesth Analg. 2007 Mar;104(3):509–
20.
128.  Dobbing J, Sands J. Quantitative growth and development of 
human brain. Arch Dis Child. 1973 Oct;48(10):757–67.
129.  Culley DJ, Xie Z, Crosby G. General Anaesthetic-induced 
neurotoxicity: an emerging problem for the young and old? Curr 
Opinion Anaesthesiol. 2007 Oct;20(5):408–13.
130.  Lapin SL, Auden SM, Goldsmith LJ, et al. Effects of sevoflurane 
anaesthesia on recovery in children: a comparison with halothane. 
Paediatr Anaesth. 1999;9(4):299–304.
131.  Beskow A, Westrin P. Sevoflurane causes more postoperative 
agitation in children than does halothane. Acta Anaesthesiol Scand. 
1999 May;43(5):536–41.
Received: 19-05-2015 Accepted: 30-11-2015
spines in the rat medial prefrontal cortex. Anaesthesiology. 2011 
Aug;115(2):282–93.
99.  Head BP, Patel HH, Niesman IR, et al. Inhibition of p75 neurotrophin 
receptor attenuates isoflurane-mediated neuronal apoptosis 
in the neonatal central nervous system. Anaesthesiology. 2009 
Apr;110(4):813–25.
100.  Sall JW, Stratmann G, Leong J, et al. Isoflurane inhibits growth but 
does not cause cell death in hippocampal neural precursor cells 
grown in culture. Anaesthesiology. 2009 Apr;110(4):826–33.
101.  Lunardi N, Hucklenbruch C, Latham JR, et al. Isoflurane impairs 
immature astroglia development in vitro: the role of actin 
cytoskeleton. J Neuropathol Exp Neurol. 2011 Apr;70(4):281–91.
102.  Zhu C, Gao J, Karlsson N, et al. Isoflurane anaesthesia induced 
persistent, progressive memory impairment, caused a loss of neural 
stem cells, and reduced neurogenesis in young, but not adult, 
rodents. J Cereb Blood Flow Metab. 2010 May;30(5):1017–30.
103.  Vutskits L, Gascon E, Tassonyi E, et al. Effect of ketamine on dendritic 
arbor development and survival of immature gabaergic neurons in 
vitro. Toxicol Sci. 2006 Jun;91(2):540–9.
104.  Lu LX, Yon JH, Carter LB, et al. General anaesthesia activates BDNF-
dependent neuroapoptosis in the developing rat brain. Apoptosis. 
2006 Sep;11(9):1603–15.
105.  Chalon J, Tang CK, Ramanathan S, et al. Exposure to halothane 
and enflurane affects learning function of murine progeny. Anesth 
Analg. 1981 Nov;60(11):794–7.
106.  Edwards DA, Shah HP, Cao W, et al. Bumetanide alleviates 
epileptogenic and neurotoxic effects of sevoflurane in neonatal rat 
brain. Anaesthesiology. 2010 Mar;112(3):567–75.
107.  Nakajima W, Ishida A, Lange MS, et al. Apoptosis has a prolonged 
role in the neurodegeneration after hypoxic ischemia in the 
newborn rat. J Neurosci. 2000 Nov 1;20(21):7994–8004.
108.  Wu YW, Bauer LA, Ballard RA, et al. Erythropoietin for neuroprotection 
in neonatal encephalopathy: safety and pharmacokinetics. 
Paediatrics. 2012 Oct;130(4):683–91.
109.  Takadera T, Ishida A, Ohyashiki T. Ketamine-induced apoptosis in 
cultured rat cortical neurons. Toxicol Appl Pharmacol. 2006 Jan 
1;210(1–2):100–7.
110.  Takadera T, Matsuda I, Ohyashiki T. Apoptotic cell death and 
caspase-3 activation induced by N-methyl-D-aspartate receptor 
antagonists and their prevention by insulin-like growth factor I. J 
Neurochem. 1999 Aug;73(2):548–56.
111.  Wu Y, Shang Y, Sun S, et al. Erythropoietin prevents PC12 cells from 
1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/
GSK-3beta/caspase-3 mediated signaling pathway. Apoptosis. 2007 
Aug;12(8):1365–75.
112.  Shang Y, Wu Y, Yao S, et al. Protective effect of erythropoietin against 
ketamine-induced apoptosis in cultured rat cortical neurons: 
involvement of PI3 K/Akt and GSK-3 beta pathway. Apoptosis. 2007 
Dec;12(12):2187–95.
113.  Pellegrini L, Bennis Y, Velly L, et al. Erythropoietin protects newborn 
rat against sevoflurane-induced neurotoxicity. Paediatr Anaesth. 
2014 Jul;24(7):749–59.
114.  Ponten E, Viberg H, Gordh T, et al. Clonidine abolishes the adverse 
effects on apoptosis and behaviour after neonatal ketamine 
exposure in mice. Acta Anaesthesiol Scand. 2012 Sep;56(8):1058–
65.
